Journal of Global Infectious Diseases

MICROBIOLOGY REPORTS
Year
: 2015  |  Volume : 7  |  Issue : 2  |  Page : 78--84

Study of antibiotic resistance pattern in methicillin resistant staphylococcus aureus with special reference to newer antibiotic


Dardi Charan Kaur, Sadhana Sanjay Chate 
 Department of Microbiology, Maharashtra Institute of Medical Education and Research Medical College, Talegaon, Dabhade, Pune, Maharashtra, India

Correspondence Address:
Dardi Charan Kaur
Department of Microbiology, Maharashtra Institute of Medical Education and Research Medical College, Talegaon, Dabhade, Pune, Maharashtra
India

The worldwide epidemic of antibiotic resistance is in danger of ending the golden age of antibiotic therapy. Resistance impacts on all areas of medicine, and is making successful empirical therapy much more difficult to achieve. Staphylococcus aureus demonstrates a unique ability to quickly respond to each new antibiotic with the development of a resistance mechanism, starting with penicillin,until the most recent, linezolid and daptomycin. Methicillin resistant S. aureus (MRSA) has become endemic today in hospitals worldwide. Resistance to the newer antimicrobial-agents - linezolid, vancomycin, teicoplanin, and daptomycin are been reported and also the fear of pandrug-resistance. This study was carried out to know the antimicrobial resistant pattern of MRSA to newer antibiotic, to know any isolates are extensively-drug resistant (XDR)/pandrug resistant (PDR), inducible macrolide-lincosamide streptogramin B (iMLSB), and mupirocin resistance. Thirty-six MRSA isolates resistant to the routinely tested antibiotic were further tested for list of antibiotic by a group of international experts. Isolates were tested for iMLSB and mupirocin resistance by the disk diffusion method. Of 385 MRSA, 36 (9.35%) isolates of MRSA were resistant to the routinely tested antibiotic. Among these 36 MRSA isolates, none of our isolates were XDR/PDR or showed resistant to anti-MRSA cephalosporins (ceftaroline), phosphonic acids, glycopeptides, glycylcyclines, and fucidanes. Lower resistance was seen in oxazolidinones (2.78%), streptogramins (5.56%), lipopeptide (5.56%). Thirty-four (94.44%) isolates showed constitutive MLSB (cMLSB) resistance and two (5.56%) iMLSB phenotypes. High- and low-level mupirocin resistance were seen in 13 (36.11%) and six (16.67%), respectively. In our study, none of our isolates were XDR or PDR. No resistance was observed to ceftaroline, telavancin, teicoplanin, and vancomycin; but the presence of linezolid resistance (1, 2.28%) and daptomycin resistance (2, 5.56%) in our rural set-up is a cause of concern.


How to cite this article:
Kaur DC, Chate SS. Study of antibiotic resistance pattern in methicillin resistant staphylococcus aureus with special reference to newer antibiotic.J Global Infect Dis 2015;7:78-84


How to cite this URL:
Kaur DC, Chate SS. Study of antibiotic resistance pattern in methicillin resistant staphylococcus aureus with special reference to newer antibiotic. J Global Infect Dis [serial online] 2015 [cited 2019 Jun 15 ];7:78-84
Available from: http://www.jgid.org/article.asp?issn=0974-777X;year=2015;volume=7;issue=2;spage=78;epage=84;aulast=Kaur;type=0